ORIC insider transaction filings
Oric Pharmaceuticals, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-28. Screen ORIC transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 3 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings by 2 insiders — 90,400 shares, $1,214,876 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 77,000 shares @ $13.69 ($1,053,814) by Piscitelli Dominic, filed 2026-08-28.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Piscitelli Dominic — Chief Financial Officer | 1 | — | 1 leg · 77,000 sh · $1,053,814 | 4 |
| Heyman Richard A. — Director | 2 | — | 3 legs · 13,400 sh · $161,062 | 2 |
Recent Form 4 filings — Oric Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | Piscitelli Dominic — Chief Financial Officer | Option exercise (M): 52,000 @ $4.36 · Option exercise (M): 25,000 @ $6 · Sale (S): 77,000 @ $13.69 · Option exercise (M): 52,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Heyman Richard A. — Director | Option exercise (M): 3,500 @ $1.60 · Sale (S): 7,000 @ $12.02 · Sale (S): 6,100 @ $12.02 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Heyman Richard A. — Director | Sale (S): 300 @ $12 | EDGAR |
| 2026-02-26 | 4 | Piscitelli Dominic — Chief Financial Officer | Option exercise (M): 52,000 @ $4.36 · Sale (S): 52,000 @ $13.51 · Option exercise (M): 52,000 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Heyman Richard A. — Director | Sale (S): 3,500 @ $12.00 · Sale (S): 3,200 @ $12.00 | EDGAR |
| 2026-01-06 | 4 | Piscitelli Dominic — Chief Financial Officer | Grant/award (A): 206,500 (derivative) @ $0 · Grant/award (A): 34,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | You Angie — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Grant/award (A): 675,000 (derivative) @ $0 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Multani Pratik S — Chief Medical Officer | Grant/award (A): 214,000 (derivative) @ $0 · Grant/award (A): 35,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Heyman Richard A. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Dier Mardi — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Kunkel Lori Anne — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Hoerter Steven L. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Piscitelli Dominic — Chief Financial Officer | Option exercise (M): 29,333 @ $0 · Sale (S): 10,720 @ $9.06 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 11,333 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Option exercise (M): 83,666 @ $0 · Sale (S): 33,374 @ $9.06 · Option exercise (M): 22,000 (derivative) @ $0 · Option exercise (M): 28,333 (derivative) @ $0 · Option exercise (M): 33,333 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Multani Pratik S — Chief Medical Officer | Option exercise (M): 29,333 @ $0 · Sale (S): 10,720 @ $9.06 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 11,333 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Kunkel Lori Anne — Director | Option exercise (M): 10,000 @ $7.90 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Kunkel Lori Anne — Director | Option exercise (M): 5,534 @ $3.75 · Option exercise (M): 5,534 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Piscitelli Dominic — Chief Financial Officer | Option exercise (M): 11,000 @ $4.36 · Sale (S): 11,000 @ $14.52 · Option exercise (M): 11,000 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Sale (S): 37,461 @ $12.32 | EDGAR |
| 2025-10-03 | 4 | Heyman Richard A. — Director | Option exercise (M): 31,353 @ $1.60 · Option exercise (M): 1,447 @ $3.75 · Option exercise (M): 13,228 (derivative) @ $0 · Option exercise (M): 18,125 (derivative) @ $0 · Option exercise (M): 1,447 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Sale (S): 34,538 @ $12.01 · Sale (S): 53,001 @ $12.05 | EDGAR |
| 2025-09-24 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Sale (S): 125,000 @ $10.80 | EDGAR |
| 2025-07-02 | 4 | Piscitelli Dominic — Chief Financial Officer | Sale (S): 20,000 @ $10.05 | EDGAR |
| 2025-06-24 | 4 | Piscitelli Dominic — Chief Financial Officer | Sale (S): 584 @ $10 · Sale (S): 450 @ $10.01 · Sale (S): 32,466 @ $10.50 | EDGAR |
| 2025-06-23 | 4 | You Angie — Director | Purchase (P): 26,597 @ $9.39 · Purchase (P): 1,403 @ $9.43 | EDGAR |
| 2025-06-13 | 4 | Piscitelli Dominic — Chief Financial Officer | Sale (S): 300 @ $10 | EDGAR |
| 2025-06-11 | 4 | Piscitelli Dominic — Chief Financial Officer | Sale (S): 324 @ $10 · Sale (S): 1,276 @ $10 · Sale (S): 1,700 @ $10.01 | EDGAR |
| 2025-06-09 | 4 | Piscitelli Dominic — Chief Financial Officer | Sale (S): 2,600 @ $10.01 · Sale (S): 300 @ $10 | EDGAR |
| 2025-03-04 | 4 | Kunkel Lori Anne — Director | Option exercise (M): 27,666 @ $3.75 · Option exercise (M): 20,500 @ $6.33 · Option exercise (M): 27,666 (derivative) @ $0 · Option exercise (M): 20,500 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | You Angie — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Heyman Richard A. — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Dier Mardi — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Kunkel Lori Anne — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Hoerter Steven L. — Director | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Piscitelli Dominic — Chief Financial Officer | Grant/award (A): 202,500 (derivative) @ $0 · Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Multani Pratik S — Chief Medical Officer | Grant/award (A): 202,500 (derivative) @ $0 · Grant/award (A): 34,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Piscitelli Dominic — Chief Financial Officer | Option exercise (M): 24,042 @ $0 · Sale (S): 8,851 @ $8.28 · Option exercise (M): 6,042 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Option exercise (M): 67,000 @ $0 · Sale (S): 24,660 @ $8.28 · Option exercise (M): 16,667 (derivative) @ $0 · Option exercise (M): 22,000 (derivative) @ $0 · Option exercise (M): 28,333 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Multani Pratik S — Chief Medical Officer | Option exercise (M): 24,042 @ $0 · Sale (S): 8,850 @ $8.28 · Option exercise (M): 6,042 (derivative) @ $0 · Option exercise (M): 8,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | You Angie — Director | Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Heyman Richard A. — Director | Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Dier Mardi — Director | Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Kunkel Lori Anne — Director | Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Hoerter Steven L. — Director | Grant/award (A): 25,600 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Kunkel Lori Anne — Director | Option exercise (M): 20,500 @ $3.75 · Option exercise (M): 20,500 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Sale (S): 40,000 @ $16.21 | EDGAR |
| 2024-02-08 | 4 | Chacko Jacob — PRESIDENT AND CEO, Director | Sale (S): 13,958 @ $12.12 · Sale (S): 26,042 @ $12.29 | EDGAR |
| 2024-01-03 | 4 | Multani Pratik S — Chief Medical Officer | Grant/award (A): 180,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Oric Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-08 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ORIC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →